Is AMER3 p.Glu780Asp (c.2340G>C) pathogenic?

AMER3 p.Glu780Asp (c.2340G>C) is classified Uncertain significance in AMER3 (ClinVar, Single submitter, 1 submitter; last evaluated 2025-09-26). AlphaMissense: likely benign (0.1147); Ultra-rare (popmax 0.0947%, sas).

How common is AMER3 p.Glu780Asp (c.2340G>C) in the general population?

AMER3 p.Glu780Asp (c.2340G>C) is ultra-rare (popmax 0.0947%, sas) (gnomAD).

What do computational predictors say about AMER3 p.Glu780Asp (c.2340G>C)?

AlphaMissense predicts likely benign (score 0.1147) — an in-silico prediction, not a clinical call.

AMER3 p.Glu780Asp

c.2340G>C · rs368377961 · VCV2455882

Uncertain significance Single submitter

Classification

Uncertain significance

ClinVar

Review

Single submitter ★☆☆☆

ClinVar · 1 submitter

AlphaMissense

likely benign

0.1147 · ACMG-weighted

gnomAD v4.1

Rare

ultra-rare (popmax 0.0947%, sas)

Missense predictors

0/3 damaging

AlphaMissense, REVEL, SaProt

Computational evidence

Protein change
AlphaMissense	0.1147	likely benign
REVEL	0.035	moderately benign-leaning
SaProt	LLR -7.22	tolerated
⇒ AlphaMissense, REVEL and SaProt all call this tolerated.
Splicing
SpliceAI	—	not assessed · no allele here is in the release
Constraint at this position
Conservation	phyloP 0.53	GERP -1.3
Regional constraint	o/e 1.05	unconstrained · MANE · 2,582 bp · p 0.068 · regional, not allelic
Overall
CADD	2.821	PHRED · no single calibrated threshold — expert panels disagree

ClinVar classifies this uncertain; the computational predictors unanimously lean tolerated — a triage signal, not a reclassification

AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.

Population frequency

gnomAD v4.1 · exomes + genomes

Grpmax group 0.0947% South Asian · 86/90,792 alleles

Filtering AF 0.0785% ClinGen BA1/BS1 input FAF95, joint · FAF99 0.0725%

Overall 0.0121% 195/1,611,466 alleles · ultra-rare

Ancestry group	Frequency	1 in
South Asiangrpmax	0.0947%	1,056
Ashkenazi Jewishnot grpmax-eligible	0.0541%	1,847
Middle Eastern	0.0329%	3,039
Remaining individualsnot grpmax-eligible	0.0144%	6,932
European (non-Finnish)	0.00695%	14,382

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene: AMER3
Protein: p.Glu780Asp
Coding: c.2340G>C
MANE Select: NM_152698
dbSNP: rs368377961
Type: single nucleotide variant
Location: chr2:130764412 (GRCh38)
Structure: AlphaFold pLDDT 45.30

Full AMER3 gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Similar variants

AMER3 p.Ala175Val Uncertain significance ★ ⚠ same type
AMER3 p.Ala25Thr Uncertain significance ★ ⚠ same type
AMER3 p.Ala345Ser Uncertain significance ★ ⚠ same type
AMER3 p.Ala402Asp Uncertain significance ★ ⚠ same type
AMER3 p.Ala557Thr Uncertain significance ★ ⚠ same type
AMER3 p.Ala55Thr Uncertain significance ★ ⚠ same type
AMER3 p.Ala579Thr Uncertain significance ★ ⚠ same type
AMER3 p.Ala588Pro Uncertain significance ★ ⚠ same type

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/amer3-p-glu780asp (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown